Clinical trial
Study Of Pharmacogenetic Risk Factors For Avascular Necrosis CCG 1882
NCT00898469 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study Of Pharmacogenetic Risk Factors For Avascular Necrosis CCG 1882
- Lead sponsor
- Children's Oncology Group
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 31, 2005
- Completion date
- May 31, 2016
- Enrollment
- 671 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.